Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel

Susan M. Carlton, Shengtai Zhou, Junhui Du, Gregory L. Hargett, Guangchen Ji, Richard E. Coggeshall

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Activation of peripheral somatostatin receptors (SSTRs) inhibits sensitization of nociceptors, thus having a short term or phasic effect [Pain 90 (2001) 233] as well as maintaining a tonic inhibitory control over nociceptors [J Neurosci 21 (2001) 4042]. The present study provides several lines of evidence that an important mechanism underlying SSTR modulation of nociceptors is regulation of the transient receptor potential vanilloid 1 ion channel (TRPV1, formerly the VR1 receptor). Double labeling of L5 dorsal root ganglion cells demonstrates that ∼60% of SSTR2a-labeled cells are positive for TRPV1. Conversely, ∼33% of TRPV1-labeled cells are positive for SSTR2a. In vivo behavioral studies demonstrate that intraplantar injection of 20.0 but not 2.0 μM octreotide (OCT, SSTR agonist) significantly reduces capsaicin (CAP, a ligand for TRPV1) -induced flinching and lifting/licking behaviors. This occurs through local activation of SSTRs in the injected hindpaw and is reversed following co-application of the SSTR antagonist cyclo-somatostatin (c-SOM). In vitro studies using a skin-nerve preparation demonstrate that activation of peripheral SSTRs on nociceptors with 20.0 μM OCT significantly reduces CAP-induced activity and can prevent CAP-induced desensitization. Furthermore, blockade of peripheral SSTRs with c-SOM dramatically enhances CAP-induced behaviors and nociceptor activity, demonstrating SSTR-induced tonic inhibitory modulation of TRPV1. Finally, TRPV1 does not appear to be under tonic opioid receptor control since the opioid antagonist naloxone does not change CAP-induced excitation and does not effect OCT-induced inhibition of CAP responses. These data strongly suggest that SSTRs modulate nociceptors through phasic and tonic regulation of peripheral TRPV1 receptors.

Original languageEnglish (US)
Pages (from-to)616-627
Number of pages12
JournalPain
Volume110
Issue number3
DOIs
StatePublished - Aug 2004

Fingerprint

Somatostatin Receptors
Somatostatin
Ion Channels
Nociceptors
vanilloid receptor subtype 1
Octreotide
Narcotic Antagonists
Capsaicin
Spinal Ganglia
Opioid Receptors
Naloxone
Ligands
Pain
Skin
Injections

Keywords

  • Capsaicin
  • Hyperalgesia
  • Nociception
  • Primary afferent
  • Somatostatin
  • VR1

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neurology
  • Neuroscience(all)
  • Pharmacology
  • Clinical Psychology

Cite this

Carlton, S. M., Zhou, S., Du, J., Hargett, G. L., Ji, G., & Coggeshall, R. E. (2004). Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. Pain, 110(3), 616-627. https://doi.org/10.1016/j.pain.2004.04.042

Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. / Carlton, Susan M.; Zhou, Shengtai; Du, Junhui; Hargett, Gregory L.; Ji, Guangchen; Coggeshall, Richard E.

In: Pain, Vol. 110, No. 3, 08.2004, p. 616-627.

Research output: Contribution to journalArticle

Carlton, SM, Zhou, S, Du, J, Hargett, GL, Ji, G & Coggeshall, RE 2004, 'Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel', Pain, vol. 110, no. 3, pp. 616-627. https://doi.org/10.1016/j.pain.2004.04.042
Carlton, Susan M. ; Zhou, Shengtai ; Du, Junhui ; Hargett, Gregory L. ; Ji, Guangchen ; Coggeshall, Richard E. / Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. In: Pain. 2004 ; Vol. 110, No. 3. pp. 616-627.
@article{6a69c62c942b4296a375cd925497afbc,
title = "Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel",
abstract = "Activation of peripheral somatostatin receptors (SSTRs) inhibits sensitization of nociceptors, thus having a short term or phasic effect [Pain 90 (2001) 233] as well as maintaining a tonic inhibitory control over nociceptors [J Neurosci 21 (2001) 4042]. The present study provides several lines of evidence that an important mechanism underlying SSTR modulation of nociceptors is regulation of the transient receptor potential vanilloid 1 ion channel (TRPV1, formerly the VR1 receptor). Double labeling of L5 dorsal root ganglion cells demonstrates that ∼60{\%} of SSTR2a-labeled cells are positive for TRPV1. Conversely, ∼33{\%} of TRPV1-labeled cells are positive for SSTR2a. In vivo behavioral studies demonstrate that intraplantar injection of 20.0 but not 2.0 μM octreotide (OCT, SSTR agonist) significantly reduces capsaicin (CAP, a ligand for TRPV1) -induced flinching and lifting/licking behaviors. This occurs through local activation of SSTRs in the injected hindpaw and is reversed following co-application of the SSTR antagonist cyclo-somatostatin (c-SOM). In vitro studies using a skin-nerve preparation demonstrate that activation of peripheral SSTRs on nociceptors with 20.0 μM OCT significantly reduces CAP-induced activity and can prevent CAP-induced desensitization. Furthermore, blockade of peripheral SSTRs with c-SOM dramatically enhances CAP-induced behaviors and nociceptor activity, demonstrating SSTR-induced tonic inhibitory modulation of TRPV1. Finally, TRPV1 does not appear to be under tonic opioid receptor control since the opioid antagonist naloxone does not change CAP-induced excitation and does not effect OCT-induced inhibition of CAP responses. These data strongly suggest that SSTRs modulate nociceptors through phasic and tonic regulation of peripheral TRPV1 receptors.",
keywords = "Capsaicin, Hyperalgesia, Nociception, Primary afferent, Somatostatin, VR1",
author = "Carlton, {Susan M.} and Shengtai Zhou and Junhui Du and Hargett, {Gregory L.} and Guangchen Ji and Coggeshall, {Richard E.}",
year = "2004",
month = "8",
doi = "10.1016/j.pain.2004.04.042",
language = "English (US)",
volume = "110",
pages = "616--627",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel

AU - Carlton, Susan M.

AU - Zhou, Shengtai

AU - Du, Junhui

AU - Hargett, Gregory L.

AU - Ji, Guangchen

AU - Coggeshall, Richard E.

PY - 2004/8

Y1 - 2004/8

N2 - Activation of peripheral somatostatin receptors (SSTRs) inhibits sensitization of nociceptors, thus having a short term or phasic effect [Pain 90 (2001) 233] as well as maintaining a tonic inhibitory control over nociceptors [J Neurosci 21 (2001) 4042]. The present study provides several lines of evidence that an important mechanism underlying SSTR modulation of nociceptors is regulation of the transient receptor potential vanilloid 1 ion channel (TRPV1, formerly the VR1 receptor). Double labeling of L5 dorsal root ganglion cells demonstrates that ∼60% of SSTR2a-labeled cells are positive for TRPV1. Conversely, ∼33% of TRPV1-labeled cells are positive for SSTR2a. In vivo behavioral studies demonstrate that intraplantar injection of 20.0 but not 2.0 μM octreotide (OCT, SSTR agonist) significantly reduces capsaicin (CAP, a ligand for TRPV1) -induced flinching and lifting/licking behaviors. This occurs through local activation of SSTRs in the injected hindpaw and is reversed following co-application of the SSTR antagonist cyclo-somatostatin (c-SOM). In vitro studies using a skin-nerve preparation demonstrate that activation of peripheral SSTRs on nociceptors with 20.0 μM OCT significantly reduces CAP-induced activity and can prevent CAP-induced desensitization. Furthermore, blockade of peripheral SSTRs with c-SOM dramatically enhances CAP-induced behaviors and nociceptor activity, demonstrating SSTR-induced tonic inhibitory modulation of TRPV1. Finally, TRPV1 does not appear to be under tonic opioid receptor control since the opioid antagonist naloxone does not change CAP-induced excitation and does not effect OCT-induced inhibition of CAP responses. These data strongly suggest that SSTRs modulate nociceptors through phasic and tonic regulation of peripheral TRPV1 receptors.

AB - Activation of peripheral somatostatin receptors (SSTRs) inhibits sensitization of nociceptors, thus having a short term or phasic effect [Pain 90 (2001) 233] as well as maintaining a tonic inhibitory control over nociceptors [J Neurosci 21 (2001) 4042]. The present study provides several lines of evidence that an important mechanism underlying SSTR modulation of nociceptors is regulation of the transient receptor potential vanilloid 1 ion channel (TRPV1, formerly the VR1 receptor). Double labeling of L5 dorsal root ganglion cells demonstrates that ∼60% of SSTR2a-labeled cells are positive for TRPV1. Conversely, ∼33% of TRPV1-labeled cells are positive for SSTR2a. In vivo behavioral studies demonstrate that intraplantar injection of 20.0 but not 2.0 μM octreotide (OCT, SSTR agonist) significantly reduces capsaicin (CAP, a ligand for TRPV1) -induced flinching and lifting/licking behaviors. This occurs through local activation of SSTRs in the injected hindpaw and is reversed following co-application of the SSTR antagonist cyclo-somatostatin (c-SOM). In vitro studies using a skin-nerve preparation demonstrate that activation of peripheral SSTRs on nociceptors with 20.0 μM OCT significantly reduces CAP-induced activity and can prevent CAP-induced desensitization. Furthermore, blockade of peripheral SSTRs with c-SOM dramatically enhances CAP-induced behaviors and nociceptor activity, demonstrating SSTR-induced tonic inhibitory modulation of TRPV1. Finally, TRPV1 does not appear to be under tonic opioid receptor control since the opioid antagonist naloxone does not change CAP-induced excitation and does not effect OCT-induced inhibition of CAP responses. These data strongly suggest that SSTRs modulate nociceptors through phasic and tonic regulation of peripheral TRPV1 receptors.

KW - Capsaicin

KW - Hyperalgesia

KW - Nociception

KW - Primary afferent

KW - Somatostatin

KW - VR1

UR - http://www.scopus.com/inward/record.url?scp=3843078843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843078843&partnerID=8YFLogxK

U2 - 10.1016/j.pain.2004.04.042

DO - 10.1016/j.pain.2004.04.042

M3 - Article

VL - 110

SP - 616

EP - 627

JO - Pain

JF - Pain

SN - 0304-3959

IS - 3

ER -